COSENTYX
COSENTYX
Approved
DIN Number
02438062
Drug Class
Human
Market Date
N/A
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02438062
AIG Number0156650001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC10 SECUKINUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
SECUKINUMABActive
Strength: 150 MG / ML
Monograph: SECUKINUMAB